# GLP-1 users face 6 rebound risks after stopping the weight-loss drugs

> HelixNews · Web page: https://helixnews.one/story/2482966 · All pages for agents: https://helixnews.one/llms.txt

2 outlets covering · First listed: NY Post, Nov 12, 2026, 3:17 PM · Read it: <https://nypost.com/2026/11/12/health/doctor-reveals-6-rebound-risks-glp-1-users-face-after-stopping/>

While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.

## Who's covering it

In the order they published:

- Nov 12, 2026, 7:00 AM: [Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns](<https://www.foxnews.com/health/ozempic-zepbound-users-face-6-rebound-risks-stopping-doctor-warns>) — Fox News (TV network, United States, rated Right)
  Thinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.
- Nov 12, 2026, 3:17 PM: [GLP-1 users face 6 rebound risks after stopping the weight-loss drugs](<https://nypost.com/2026/11/12/health/doctor-reveals-6-rebound-risks-glp-1-users-face-after-stopping/>) — NY Post (Newspaper, United States, rated Lean right)
  While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.